Skip to main navigation

preloader

Overview
News & Events
- News Releases
- Events
Presentations
SEC Filings
Stock Info
- Analyst Coverage
Corporate Governance
Resources & Contact

News Releases

Year

Cullinan Oncology Provides Corporate Update and Reports Second Quarter 2022 Financial Results

August 10, 2022

Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 1, 2022

Cullinan Oncology to Participate in BTIG Biotechnology Conference and Canaccord Growth Conference

August 1, 2022

Cullinan Oncology to Participate in William Blair Biotech Focus Conference

July 5, 2022

Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

July 1, 2022

Cullinan Oncology and Taiho Pharmaceutical Complete Agreement for Strategic Collaboration to Jointly Develop and Commercialize CLN-081/TAS6417

June 23, 2022

Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

June 1, 2022

Cullinan Oncology to Present Updated Data Demonstrating the Therapeutic Potential of CLN-081 in Patients with EGFR Exon 20 Insertion Mutation Positive Non-Small Cell Lung Cancer at the 2022 ASCO Annual Meeting

May 31, 2022

Cullinan Oncology to Host Analyst and Investor Briefing at 2022 ASCO Annual Meeting

May 26, 2022

Cullinan Oncology to Present at H.C. Wainwright Global Investment Conference

May 19, 2022

Pagination

First page
Previous page
Page 1
Current page 2
Page 3
Page 4
Next page
Last page

Displaying 11 - 20 of 36

Investor Tools

News & Events
- News Releases
- Events

Stock Info
- Stock Quote & Chart

Corporate Governance

Financials & Filings

IR Resources

Copyright © 2022 Cullinan Oncology, Inc.. All rights reserved

Site - Footer

Terms of Use/Privacy